Cancer, Neoplasms (Cancer / Tumors)
Conditions
Brief summary
This study aims to determine the effect of mandala coloring on the quality of life in cancer patients. Conducting a quasi-experimental design with a pretest-posttest control group, the study will involve a total of 76 cancer patients hospitalized in an oncology ward. Participants will be assigned to either the experimental (mandala) group or the control group. At the baseline, data will be collected face-to-face using a Patient Information Form and the EORTC QLQ-C30 Version 3.0 Quality of Life Scale. Patients in the experimental group will be provided with a mandala coloring book and colored pencils, and they will practice mandala coloring for 30 minutes, at least twice a week, over a 3-week period. The control group will receive routine clinical care with no intervention. After 3 weeks, the EORTC QLQ-C30 scale will be re-administered to both groups to evaluate and compare changes in their quality of life.
Interventions
BEHAVIORALMandala Coloring
Patients in the experimental group will be provided with a mandala coloring book and a set of 12 colored pencils. They will be requested to practice mandala coloring in a quiet, distraction-free environment for 30 minutes, at least twice a week, for a total duration of 3 weeks. The intervention will be conducted in addition to routine clinical care.
Sponsors
Emine TARLABELEN KARAYTUĞ
The Scientific and Technological Research Council of Turkey
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosed with cancer * Aged 18 years and older * Voluntarily willing to participate in the study * Able to hold and use a pencil for coloring
Exclusion criteria
* Refusing to participate or withdraws consent before the study begins * Unable to comply regularly with the scheduled mandala coloring program * Incapable of using a pencil due to physical or cognitive impairments
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life Score via EORTC QLQ-C30 | Baseline and 3 weeks | Quality of life will be evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) Version 3.0. The questionnaire includes 30 items. All raw scores are linearly transformed into a standard scale ranging from 0 to 100. For the global health and functional scales, a higher score indicates a better quality of life. For the symptom scales, a higher score indicates a worse outcome. |
Countries
Turkey (Türkiye)
Contacts
CONTACTEmine Tarlabelen Karaytug, Research Assistant, PhD
Outcome results
None listed